Skip to main content

Table 2 Determinants of unfavorable treatment outcome at 60 months among those active in treatment at month six

From: Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia

Variable Sub-category Hazard ratio, crude P- value Hazard ratio, adj P-value
Age <15 1   1  
≥15 1.6 0.001 1.6 0.002
Gender Female 1   1  
Male 1.3 <0.001 1.2 <0.001
Baseline WHO Stage I or II 1   1  
III or IV 1.5 <0.001 1.4 <0.001
Baseline CD4 <100 1   1  
100–349 0.7 <0.001 0.8 <0.001
≥350 0.8 0.008 0.9 0.106
Ever discontinued HAART before 6 months No 1   1  
Yes 1.8 0.000 1.9 0.000